Objective-Regulation of angiogenesis is critical for many diseases. Specifically, pathological retinal neovascularization, a major cause of blindness, is suppressed with dietary ω3-long-chain polyunsaturated fatty acids (ω3LCPUFAs) through antiangiogenic metabolites of cyclooxygenase and lipoxygenase. Cytochrome P450 epoxygenases (CYP2C8) also metabolize LCPUFAs, producing bioactive epoxides, which are inactivated by soluble epoxide hydrolase (sEH) to transdihydrodiols. The effect of these enzymes and their metabolites on neovascularization is unknown. Approach and Results-The mouse model of oxygen-induced retinopathy was used to investigate retinal neovascularization.
P athological neovascularization in retinopathy is a major cause of blindness. 1,2 ω3 long-chain polyunsaturated fatty acids (ω3LCPUFA), docosahexaenoic acid (DHA), and eicosapentaenoic acid (EPA) suppress retinal neovascularization and improve visual function in animal and clinical retinopathy studies 3, 4 through metabolites of cyclooxygenase and lipoxygenase. 3, [5] [6] [7] Cytochrome P450s (CYPs) also metabolize both ω3LCPUFAs and ω6LCPUFAs into bioactive epoxides, which are hydrolyzed by soluble epoxide hydrolase (sEH) to form less active transdihydrodiols (diols), hence dampening the biological effects of LCPUFA epoxides ( Figure 1A ). 8, 9 It is important to further elucidate enzymes that generate bioactive ω3LCPUFA (and ω6LCPUFA) metabolites (CYP2C) and enzymes that deactivate them (sEH) to identify pro-and antiangiogenic pathways.
CYP2C8, a dominant human epoxygenase, is induced by hypoxia, 10 which in turn is critical in retinal neovascular development. sEH is implicated in cardiovascular diseases 11 and expressed in endothelial cells (ECs) 12 and may regulate angiogenesis. ω6LCPUFA-derived epoxyeicosatrienoic acids (EETs), synthesized by CYP2C8 from arachidonic acid (AA), promote angiogenesis and EC migration. [13] [14] [15] [16] [17] However, the angiogenic effect of ω3LCPUFA-derived epoxy metabolites from CYP2C8: DHA-derived epoxydocosapentaenoic acids (EDPs) and EPA-derived epoxyeicosatetraenoic acids (EEQs; Figure 1A ) is unknown. 18 Both EDPs and EEQs exhibit potent March 2014 vasodilatory and cardioprotective effects, 19 with EDPs suggested to suppress EC migration and angiogenesis in tumors. 20 We investigated whether CYP2C8 and its ω3LCPUFA metabolites promoted or suppressed retinal neovascularization using blood vessel system-specific CYP2C8 and sEH-overexpressing mice (Tie2-CYP2C8-Tg, Tie2-sEH-Tg) 21 and germ-line knockout of sEH (sEH -/-) with wild-type (WT) littermate controls with a ω3LCPUFA-enriched diet in a mouse model of oxygen-induced retinopathy (OIR). CYP2C8 and sEH metabolites from a ω6LCPUFA-enriched diet were examined similarly in OIR.
Materials and Methods
Methods and Materials are available in the online-only Supplement.
Results
CYP2C-positive leukocytes are detected in circulating cells from WT normoxic mice ( Figure 1B) . The CYP2C mRNA level is highest in blood cells and much higher in nonperfused versus perfused retina ( Figure 1C ). We then identified the source of the mouse CYP2C8 homologue, CYP2C. CYP2C-positive cells are found within blood vessel lumens in normoxic retina ( Figure 1D and 1E) and outside vessels in P17 OIR retina ( Figure 1D ), when the maximal neovascularization is observed in mouse OIR. 22, 23 Some F4/80-positive macrophages outside vessels express CYP2C in OIR, indicating macrophages are one of the sources of CYP2C in the OIR retina. Other sources are not excluded ( Figure 1F ). Pathological neovessels and neural tissue express CYP2C and sEH in OIR ( Figure 1G and 1H). We next examined whether OIR affects levels of CYP2C (producing active metabolites) or sEH (reducing active metabolite levels).
OIR Induces Increased CYP2C8 and Decreased sEH Retinal Levels, Resulting in an Increased
Retinal DHA-Derived Epoxide:Diol Ratio CYP2C (mRNA and protein) is induced in OIR retinas, whereas sEH is suppressed (P<0.05; Figure 1I and 1J). In OIR versus normoxia at P14 (on normal chow) when the neovessel formation starts, 23 the DHA-derived retinal epoxide:diol ratio (19,20-EDP:19,20-dihydroxy-docosapentaenoic acid [DiHDPA]) is increased >2-fold (P=0.017; Figure 1K ). We next determined how this increase in active metabolites influences retinal neovessel formation.
In Tie2-CYP2C8-Tg OIR Mice, ω3LCPUFA
Feed Increases Neovascularization and Increases VEGF-A Expression
With ω3LCPUFA feed, Tie2-human-CYP2C8-Tg mice develop more OIR neovascularization than WT (Tie2-CYP2C8-Tg: 7.60±0.29% versus WT: 6.40±0.33% of total retinal area; P=0.014) at P17 (Figure 2A ). Moreover, Tie2-sEH-Tg retinas develop less neovascularization in OIR (Tie2-sEH-Tg: 4.67±0.34% versus WT: 6.59±0.38%; P=0.0027; Figure 2B ). Germ-line deletion of sEH (sEH -/-) had no effect on neovascularization (sEH -/-:7.39±0.34% versus WT: 7.35±0.32%; P=0.95; Figure 2C ). With ω3LCPUFA feed, Tie2-CYP2C8-Tg OIR mice had 2.6-fold greater vascular endothelial growth factor (VEGF)-A expression than WT (P=0.011), whereas Tie2-sEH-Tg had 57% less VEGF-A expression (P=0.030). No significant difference in VEGF-C levels was detected ( Figure 2D and 2E). Significantly higher retinal interleukin-1β and interleukin-6 levels were found in Tie2-CYP2C8-Tg versus WT OIR mice ( Figure 2D ). We next examined the active and inactive metabolite levels or ratios in plasma and retina.
In OIR With ω3LCPUFA Feed, Tie2-CYP2C8-Tg Increase and Tie2-sEH-Tg Decrease Plasma Epoxide Levels and Retinal Epoxide:Diol Ratios at P17
In OIR, ω3LCPUFA-fed Tie2-CYP2C8-Tg mouse plasma has more 19,20-EDP (≈1.6-fold; P=0.029) and more 17,18-EEQ (≈1.5-fold; P=0.030) than WT. The DHA-derived 19,20-EDP level is 30-fold higher than EPA-derived 17,18-EEQ in both mutant and WT ( Figure 2F ), indicating that DHA contributes more than EPA to the effect. No significant change was found in the plasma EETs levels ( Figure IIB in the onlineonly Data Supplement). In ω3LCPUFA-fed Tie2-sEH-Tg mice, 19,20-EDP and 17,18-EEQ levels were reduced by 34% (P=0.034) and 24% (P=0.016; Figure 2G ). In OIR, ω3LCPUFA-fed Tie2-CYP2C8-Tg retinas had a 52% higher 19,20-EDP:DiHDPA ratio than WT (P=0.045; Figure 2H ); the 17,18-EEQ:17,18-dihydroxy-eicosatetraenoic acid (DHEQ) ratio was unchanged. In ω3LCPUFA-fed Tie2-sEH-Tg retinas, the 19,20-EDP:DiHDPA ratio decreased by 58% (P=0.028; Figure 2I ); the 17,18-EEQ:17,18-DHEQ ratio was unchanged. We next examined the effect of sEH and CYP2C in ex vivo transgenic mouse aortic ring sprouting to confirm our findings.
ω3LCPUFA Metabolite Promotes Aortic Vascular Sprouting From Tie2-CYP2C8-Tg Mice, Which Is Lost in Tie2-sEH-Tg Mice
The proangiogenic effect of CYP2C8 and suppressive effect of sEH with ω3LCPUFA substrate were further confirmed with aortic ring-sprouting assays. A total of 30 μmol/L DHA (versus 30 μmol/L AA as a LCPUFA DHA control) attenuated aortic sprouting in WT (P=0.01), which was abolished in Tie2-CYP2C8-Tg (P<0.05; Figure 2J ). Tie2-sEH-Tg suppressed aortic sprouting versus WT with 19,20-EDP treatment (≈50%; P<0.01; Figure 2K ), whereas there was no effect with 17,18-EEQ, confirming the relative importance of DHA versus EDP with ω3LCPUFA effects.
Discussion
Although the effects of ω3LCPUFA on human health have been reported since the beginning of the last century, 24 the knowledge of the primary mechanisms of action of these lipids is still relatively limited. 3, 5, 6, 8 We have shown previously that the 5-lipoxygenase ω3LCPUFA metabolite 4-hydroxydocosahexaenoic acid suppresses retinal neovascularization. 25 Here, we investigated whether CYP2C8, one of the dominant human CYP epoxygenases, also mediates angiogenic effects of ω3LCPUFA in pathological retinal neovascularization. We found much higher levels of mouse CYP2C homologue in nonperfused retina than perfused retina, indicating that CYP2C in normal retina comes from circulating blood cells. In OIR, CYP2C is localized in some macrophages outside vessels, consistent with migration of circulating cells from increased vascular leakage in OIR. 26 Increased retinal DHA-derived epoxide:diol ratio in OIR is consistent with increased CYP2C and decreased sEH levels.
Recruited CYP2C-expressing macrophages may contribute to the increased CYP2C in OIR retinas. The increased levels of active metabolites and decreased level of less active breakdown products in OIR, in turn, lead to an increased DHA-derived epoxide:diol ratio.
No significant difference in normal vascular development is observed in Tie2-CYP2C8-Tg and Tie2-sEH-Tg mice compared with WT littermate controls at P7 ( Figure I is increased in Tie2-CYP2C8-Tg and reduced in Tie2-sEH-Tg with ω3LCPUFA feed, suggesting a proretinopathy role of CYP2C8 ω3LCPUFA metabolites in OIR. However, unchanged neovascularization is observed in ω3LCPUFA-fed sEH -/mice, possibly because of a faster normal vascular development at P7, which is more resistant to hyperoxia ( Figure I in the online-only Data Supplement), or likely reflecting already low sEH expression in OIR. In OIR with ω3LCPUFA feed, Tie2-CYP2C8-Tg increases VEGF-A expression, whereas Tie2-sEH-Tg decreases VEGF-A expression, consistent with the neovascular phenotypes. We have shown that 5-lipoxygenase ω3LCPUFA metabolite 4-hydroxydocosahexaenoic acid suppresses retinal neovascularization without changing VEGF-A expression. 25 VEGF-A has been identified to be positively involved in retinal pathological angiogenesis. 27 These studies suggest an opposite effect on VEGF-A production of CYP2C8 ω3LCPUFA metabolites in retinal angiogenesis, possibly contributing to the increased neovessel formation.
In OIR with ω3LCPUFA feed, Tie2-CYP2C8-Tg increase and Tie2-sEH-Tg decrease plasma epoxide levels and retinal epoxide:diol ratios at P17. Higher levels of DHA-derived 19,20-EDP in both mutant and WT suggest 19,20-EDP as the main active CYP2C ω3LCPUFA metabolite versus EPA-derived 17,18-EEQ mediating a proretinopathy effect in OIR. These results suggest that with ω3LCPUFA feed, CYP2C8 may potentiate neovascularization primarily by increasing plasma 19,20-EDP and the retinal 19,20-EDP:DiHDPA ratio, which reflects both the activity of CYP2C8, which produces bioactive 19,20-EDP and the activity of sEH, which attenuates bioactivity through conversion to less active diol. The effects of CYP2C and sEH in transgenic mouse aortic ring sprouting confirm that Tie2-CYP2C8-Tg promotes angiogenesis with ω3LCPUFA (primarily DHA) and suggests that decreased neovascularization in Tie2-sEH-Tg may be directly attributable to accelerated degradation of 19,20-EDP by overexpressed sEH.
Finding new approaches to prevent or treat neovascularization are important. Here, we find a novel role of CYP2C8 (and sEH) ω3LCPUFA metabolites in retinopathy. CYP2C8 overexpression potentiates retinal neovascularization with ω3LCPUFA feed by increasing plasma DHA-derived 19,20-EDP (and increasing the retinal 19,20-EDP:DiHDPA ratio), reflecting both production and elimination of 19,20-EDP. A recent study shows that EDPs inhibit ECs migration in tumor angiogenesis by suppressing VEGF-C, but not VEGF-A, in human umbilical vein endothelial cells in vitro. 20 VEGF-C is a critical mediator of lymphangiogenesis (as well as angiogenesis) 28 and considered as an important therapeutic target for cancer. In current studies, no change in VEGF-C expression is observed in Tie2-CYP2C8-Tg and Tie2-sEH-Tg retina. The different expression pattern of VEGF-A and VEGF-C may contribute to the opposite angiogenic function of CYP2C8 metabolite 19,20-EDP observed in the retina and in tumor, indicating a tissue-specific role of CYP2C8. Previously, cardiomyocytes expressing CYP2C8 were shown to increase recovery after cardiac ischemia/reperfusion, whereas ECs expressing CYP2C8 reduced the recovery. 12 OIR neovascularization is potentiated by the CYP2C ω6LCPUFA metabolite (14,15-EET; Figures IV and V in the online-only Data Supplement) and the CYP2C ω3LCPUFA metabolite 19,20-EDP, suggesting that inhibition of CYP2C8 might reduce retinal neovascularization by suppressing ω3LCPUFA and ω6LCPUFA diet-induced proretinopathy lipid metabolites.
